TP53 and neoplasm: To confirm that the RI-TATp53C′ peptide inhibited tumor cell proliferation in a p53-dependent fashion, we compared parental p53+/+ HCT116 colorectal carcinoma cells to HCT116 cells that were rendered p53-deficient at both loci by targeted genetic recombination (Bunz et al. 1998).